45 results on '"Ahn, D."'
Search Results
2. Interface state generation of Al2O3/InGaAs MOS structures by electrical stress
3. Laser removal of lubricating oils from metal surfaces
4. 1645P STAT3, ACTA2, and SPARC stromal markers predict response to Gemcitabine/Cisplatin/Nab-paclitaxel (GCN) in patients with advanced pancreatic adenocarcinoma (apdac)
5. 1000P Real-world clinical outcomes of cabozantinib (cabo) as a second-line (2L) treatment for advanced hepatocellular carcinoma (aHCC)
6. 640P A phase II, multicenter, open-label study of PolyPEPI1018 in combination with atezolizumab in participants with relapsed or refractory microsatellite-stable metastatic colorectal (MSS mCRC) cancer (Oberto-301): Initial results
7. 616P Sequential treatment with regorafenib (REG) and trifluridine/tipiracil (TAS) +/- bevacizumab (Bev) in refractory metastatic colorectal cancer (mCRC) in community clinical practice in the USA
8. 108P FGFR2 fusions and their impact on efficacy of standard chemotherapy in patients with biliary tract cancer
9. 85 Ketogenesis promotes tolerance to Pseudomonas aeruginosa infection in the cystic fibrosis lung
10. P14-23: Effects of repeated heat-not-burn-whole cigarette smoke condensate treatment in rat liver in vivo
11. Hybrid integration of GaAs/AlGaAs in-plane-gate resonant tunneling and field effect transistors
12. Impurity scattering effects on transport through gate-all-around Si nanowires
13. Electronic transport properties of a single-wall carbon nanotube field effect transistor with deoxyribonucleic acid conjugation
14. (47) Association of High-Priority Exceptions with Mortality Among Heart Transplant Candidates
15. Gate bias controlled NDR in an in-plane-gate quantum dot transistor
16. 397P Early decreases in KRAS mutant allele frequency (MAF) predicts clinical benefit to the PLK1 inhibitor onvansertib in combination with FOLFIRI/bev in 2L treatment of metastatic colorectal carcinoma (mCRC)
17. 329P Duration of adjuvant therapy in stage III colon cancer: A real world multi-institutional US-based experience
18. P12-17 Changes in superoxides showed a reproducible and accurate screening method for mitochondrial toxicity in drug-treated mammalian cardiomyocytes
19. Electrical conduction measurement of thiol modified DNA molecules
20. Single-electron tunneling in silicon-on-insulator nano-wire transistors
21. Electrical transport through poly(G)–poly(C) DNA molecules
22. Direct observation of excited states in double quantum dot silicon single electron transistor
23. 1483P Cell-free DNA dominant clone allele frequency associates with poor outcomes in advanced pancreatic cancer
24. Fabrication of quantum dot transistors incorporating a single self-assembled quantum dot
25. P-130 Short course pelvic radiotherapy for localized and oligometastatic rectal adenocarcinoma: The Mayo Clinic experience
26. P-79 C-PRECISE-01 study: A phase Ib/II trial of MEN1611, a PI3K inhibitor, and cetuximab in patients with PIK3CA mutated metastatic colorectal cancer failing irinotecan, oxaliplatin, 5-FU and anti-EGFR containing regimens
27. P-91 A retrospective analysis of maintenance strategies in metastatic gastric and gastroesophageal cancer
28. 730P - Phase II trial of trifluridine/tipiracil (TAS-102) in patients with advanced refractory biliary tract cancer (BTC)
29. 726P - FGFR2 fusions and its effect of patient (pt) outcomes in intrahepatic cholangiocarcinoma (iCCA)
30. 667TiP - A phase Ib/II study of onvansertib (PCM-075) in combination with FOLFIRI and bevacizumab for second-line treatment of metastatic colorectal cancer in patients with a KRAS mutation
31. A robot-assisted kinematic measurement for children with attention-deficit hyperactivity disorder
32. 155O - Efficacy of TAS-120, an irreversible fibroblast growth factor receptor inhibitor (FGFRi), in patients with cholangiocarcinoma and FGFR pathway alterations previously treated with chemotherapy and other FGFRi’s
33. 735P - Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics
34. O-014 - Regorafenib Dose Optimization Study (ReDOS): Randomized phase II trial to evaluate escalating dosing strategy and pre-emptive topical steroids for regorafenib in refractory metastatic colorectal cancer (mCRC) – An ACCRU Network study
35. O-001 - Efficacy of TAS-120, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in cholangiocarcinoma patients with FGFR pathway alterations who were previously treated with chemotherapy and other FGFR inhibitors
36. EP-1140: Hypofractionated radiotherapy for early glottic cancer: retrospective analysis of single institution
37. EP-1121: Treatment of oral cavity cancer: concurrent chemoradiotherapy vs surgery followed by radiotherapy
38. C-rate performance of silicon oxycarbide anodes for Li+ batteries enhanced by carbon nanotubes
39. (316) Brainstem BDNF contributes to hyperalgesic priming in both males and females in a rat model of migraine
40. Facile synthesis of N-2(- F-hexyl)enamides
41. Electric-field dependence of the intersubband optical absorption in a semiconductor quantum well
42. Charged particle radiotherapy of paraspinal tumors
43. Microwave bandpass filters with closed loop resonators and coupled lines using YBCO thin films
44. Enhanced virtual colonoscopy system employing automatic detection of colon polyps
45. Contributors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.